MOHAMMAD ANSARI: Open Payments
NPI 1891874863 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 18 payments from 6 companies in 2025. Trend: 2023 $332 · 2024 $449 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $179 |
| Alkermes, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: VRAYLAR, ARISTADA, COBENFY, REXULTI, UZEDY, INGREZZA.
Industry payments across VA — which companies pay providers there.
